UL95_EHV2
ID UL95_EHV2 Reviewed; 347 AA.
AC Q66638;
DT 08-MAR-2011, integrated into UniProtKB/Swiss-Prot.
DT 01-NOV-1996, sequence version 1.
DT 02-JUN-2021, entry version 48.
DE RecName: Full=Gene 34 protein;
GN Name=34;
OS Equine herpesvirus 2 (strain 86/87) (EHV-2).
OC Viruses; Duplodnaviria; Heunggongvirae; Peploviricota; Herviviricetes;
OC Herpesvirales; Herpesviridae; Gammaherpesvirinae; Percavirus.
OX NCBI_TaxID=82831;
OH NCBI_TaxID=9796; Equus caballus (Horse).
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX PubMed=7783207; DOI=10.1006/jmbi.1995.0314;
RA Telford E.A.R., Watson M.S., Aird H.C., Perry J., Davison A.J.;
RT "The DNA sequence of equine herpesvirus 2.";
RL J. Mol. Biol. 249:520-528(1995).
CC -!- SIMILARITY: Belongs to the herpesviridae UL95 family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; U20824; AAC13822.1; -; Genomic_DNA.
DR PIR; S55629; S55629.
DR RefSeq; NP_042631.1; NC_001650.2.
DR GeneID; 1461047; -.
DR KEGG; vg:1461047; -.
DR Proteomes; UP000007083; Genome.
DR InterPro; IPR004280; Herpes_UL95.
DR Pfam; PF03038; Herpes_UL95; 1.
PE 3: Inferred from homology;
KW Reference proteome.
FT CHAIN 1..347
FT /note="Gene 34 protein"
FT /id="PRO_0000406071"
FT REGION 95..126
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 101..119
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 347 AA; 38555 MW; 2023BF9477EE6930 CRC64;
MFALASMTTS GDEALNARYK ESVSLSVGLC ESLPEQFKLI ETPINSFLLV ANVMPNDDRP
WDSHPASGAD FHNIRMPRLE RLRALIRCDR GYNNGKGGEA GQRAGEDDER MDEGVPEEGA
PRSPHPPPFA HYEVYDSWSW QRALRVDKDD VIREAVAELA KPANWQGTAV EDPLPLMWLL
FYGRRSFCDD PECLYRARFG HPGPLLLPNY MYRPAEDASS FLAGLCRCVR SVYGCEFGGG
SHVNPAQVPF DHGRFSEALR KLGAVDDAGA YVSRQCLVCR LYRQNLMSRG IIGGRGSSIV
LGGSGKKYLT REVGTRRCLE LGDIALYPSY DISLILDDLE ASDGLRQ